Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-26

FDA Approved: NEBIVOLOL — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approved a supplemental application for Nebivolol Hydrochloride by AvKARE, indicating an additional approval related to the generic product under ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol hydrochloride (Nebivolol hydrochloride)

Snippet

SUPPL AP for NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)